Ghrelin contributes to protection of hepatocellular injury induced by ischaemia/reperfusion

Liver International

Volumn 34, Issue 4, 2014, Pages 567-575

  Qin, Yan ^a,b   Li, Ziru ^a   Wang, Zhigang ^c   Li, Yin ^a   Zhao, Jing ^a   Mulholland, Michael ^d   Zhang, Weizhen ^a,d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Da Li University   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

AMPK; Ghrelin; Ghrelin receptor; Gut hormone; HIRI; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; GHRELIN; GHRELIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTATE DEHYDROGENASE; LIVER PROTECTIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL INFILTRATION; CELL SWELLING; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE DELETION; INFLAMMATORY CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NICK END LABELING; NONHUMAN; NULL ALLELE; REPERFUSION INJURY; UPREGULATION;

AMPK; GHRELIN; GHRELIN RECEPTOR; GUT HORMONE; HIRI; LIVER;

ALANINE TRANSAMINASE; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GHRELIN; HEPATOCYTES; IN SITU NICK-END LABELING; L-LACTATE DEHYDROGENASE; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, GHRELIN; REPERFUSION INJURY;

EID: 84895822395     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12286     Document Type: Article

References (32)

1. Mendes-Braz M, Elias-Miró M, Jiménez-Castro MB, et al. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol 2012; 2012: 1-20.
2. Canedo LF, Lima GV, Machado MC. Pulmonary effects after partial liver ischemia and reperfusion: experimental model. Rev Col Bras Cir 2012; 39: 216-21.
3. Saiman Y, Friedman SL. The role of chemokines in acute liver injury. Front Physiol 2012; 3: 1-12.
4. Ben-Ari Z, Avlas O, Fallach R, et al. Ischemia and reperfusion liver injury is reduced in the absence of Toll-like receptor 4. Cell Physiol Biochem 2012; 30: 489-98.
5. Sakai N, Van Sweringen HL, Belizaire RM, et al. IL-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 2012; 27: 1609-16.
6. Mukhopadhyay P, Horváth B, Zsengellr Z, et al. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med 2012; 53: 1123-38.
7. Yang Y-Y, Huang Y-T, Lee T-Y, et al. Rho-kinase-dependent pathway mediated the hepatoprotective effects of sorafenib for ischemia/reperfusion liver injury of NASH rats. Liver Transpl 2012; 18: 1371-83.
8. Peralta C, Bartrons R, Serafin A, et al. Adenosine monophosphate[ndash]activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164-73.
9. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
10. Muccioli G, Tschop M, Papotti M, et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002; 440: 235-54.
11. Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G948-52.
12. Chang L, Ren Y, Liu X, et al. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 2004; 43: 165-70.
13. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66.
14. Suzuki H, Matsuzaki J, Hibi T. Ghrelin and oxidative stress in gastrointestinal tract. J Clin Biochem Nutr 2011; 48: 122-5.
15. Golestan Jahromi M, Nabavizadeh F, Vahedian J, et al. Protective effect of ghrelin on acetaminophen-induced liver injury in rat. Peptides 2010; 31: 2114-7.
16. Çetin E, Kanbur M, Çetin N, Eraslan G, Atasever A. Hepatoprotective effect of ghrelin on carbon tetrachloride-induced acute liver injury in rats. Regul Pept 2011; 171: 1-5.
17. Arici ÖF, Çetin N. Protective role of ghrelin against carbon tetrachloride (CCl4)-induced coagulation disturbances in rats. Regul Pept 2011; 166: 139-42.
18. Granado M, Martin AI, Lopez-Menduina M, Lopez-Calderon A, Villanua MA. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am J Physiol Endocrinol Metab 2008; 294: E131-41.
19. Moreno M, Chaves JF, Sancho-Bru P, et al. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology 2010; 51: 974-85.
20. Işeri SÖ, Şener G, Saglam B, et al. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul Pept 2008; 146: 73-9.
21. Li Y, Hai J, Li L, et al. Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 2013; 43: 376-86.
22. Xu G, Wang Z, Li Y, et al. Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice. Diabetologia 2012; 55: 1813-23.
23. Padrissa-Altes S, Zaouali MA, Bartrons R, Rosello-Catafau J. Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms. Clin Sci 2012; 123: 93-8.
24. Jaworek J. Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006; 57(Suppl. 5): 83-96.
25. Fahim MA, Kataya H, El-Kharrag R, et al. Ghrelin attenuates gastrointestinal epithelial damage induced by doxorubicin. World J Gastroenterol 2011; 17: 3836-41.
26. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-13.
27. Smith RG, Cheng K, Schoen WR, et al. A nonpeptidyl growth hormone secretagogue. Science 1993; 260: 1640-3.
28. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004; 117: 5479-87.
29. Yang X, Qin L, Liu J, Tian L, Qian H. 17β-Estradiol protects the liver against cold ischemia/reperfusion injury through the Akt kinase pathway. J Surg Res 2012; 178: 996-1002.
30. Matsuda A, Jacob A, Wu R, et al. Milk fat globule-EGF factor VIII ameliorates liver injury after hepatic ischemia-reperfusion. J Surg Res 2012; 180: e37-46.
31. Weigand K, Brost S, Steinebrunner N, et al. Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg 2012; 2012: 1-8.
32. Luan X, Liu Y, Li M. The role of CD14 and toll-like receptor 4 of Kupffer cells in hepatic ischemia-reperfusion injury in rats. Transplant Proc 2012; 44: 937-41.